vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and monday.com Ltd. (MNDY). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $704.0M, roughly 1.4× monday.com Ltd.). monday.com Ltd. runs the higher net margin — 1.3% vs 0.7%, a 0.6% gap on every dollar of revenue. monday.com Ltd. produced more free cash flow last quarter ($224.6M vs $-6.0M).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Monday.com Ltd. is an Israeli-based cloud-based platform that allows users to create their own applications and project management software. The product was launched in 2014 and in July 2019, the company raised $150 million, based on a $1.9 billion valuation. The company went public in June 2021 and is based in Tel Aviv, Israel.

ASTH vs MNDY — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.4× larger
ASTH
$950.5M
$704.0M
MNDY
Higher net margin
MNDY
MNDY
0.6% more per $
MNDY
1.3%
0.7%
ASTH
More free cash flow
MNDY
MNDY
$230.5M more FCF
MNDY
$224.6M
$-6.0M
ASTH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASTH
ASTH
MNDY
MNDY
Revenue
$950.5M
$704.0M
Net Profit
$6.6M
$9.4M
Gross Margin
89.6%
Operating Margin
1.9%
-4.4%
Net Margin
0.7%
1.3%
Revenue YoY
42.9%
Net Profit YoY
184.4%
EPS (diluted)
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
MNDY
MNDY
Q4 25
$950.5M
Q3 25
$956.0M
$704.0M
Q2 25
$654.8M
$453.0M
Q1 25
$620.4M
$216.9M
Q4 24
$665.2M
Q3 24
$478.7M
$527.1M
Q2 24
$486.3M
$337.9M
Q1 24
$404.4M
$162.3M
Net Profit
ASTH
ASTH
MNDY
MNDY
Q4 25
$6.6M
Q3 25
$373.0K
$9.4M
Q2 25
$9.4M
$21.4M
Q1 25
$6.7M
$7.1M
Q4 24
$-7.8M
Q3 24
$16.1M
$-14.2M
Q2 24
$19.2M
$-21.7M
Q1 24
$14.8M
$-14.7M
Gross Margin
ASTH
ASTH
MNDY
MNDY
Q4 25
Q3 25
89.6%
Q2 25
89.6%
Q1 25
89.2%
Q4 24
Q3 24
89.0%
Q2 24
89.2%
Q1 24
89.5%
Operating Margin
ASTH
ASTH
MNDY
MNDY
Q4 25
1.9%
Q3 25
2.0%
-4.4%
Q2 25
3.1%
-0.7%
Q1 25
3.3%
-2.3%
Q4 24
0.1%
Q3 24
5.9%
-7.1%
Q2 24
6.2%
-10.3%
Q1 24
7.5%
-14.0%
Net Margin
ASTH
ASTH
MNDY
MNDY
Q4 25
0.7%
Q3 25
0.0%
1.3%
Q2 25
1.4%
4.7%
Q1 25
1.1%
3.3%
Q4 24
-1.2%
Q3 24
3.4%
-2.7%
Q2 24
3.9%
-6.4%
Q1 24
3.7%
-9.0%
EPS (diluted)
ASTH
ASTH
MNDY
MNDY
Q4 25
$0.12
Q3 25
$0.01
Q2 25
$0.19
Q1 25
$0.14
Q4 24
$-0.14
Q3 24
$0.33
Q2 24
$0.40
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
MNDY
MNDY
Cash + ST InvestmentsLiquidity on hand
$429.5M
$1.4B
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$1.0B
Total Assets
$2.2B
$1.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
MNDY
MNDY
Q4 25
$429.5M
Q3 25
$463.4M
$1.4B
Q2 25
$342.1M
$1.7B
Q1 25
$260.9M
$1.4B
Q4 24
$290.8M
Q3 24
$350.3M
$1.1B
Q2 24
$327.7M
$1.3B
Q1 24
$337.3M
$1.1B
Stockholders' Equity
ASTH
ASTH
MNDY
MNDY
Q4 25
$779.3M
Q3 25
$775.5M
$1.0B
Q2 25
$765.5M
$1.2B
Q1 25
$745.4M
$1.0B
Q4 24
$712.7M
Q3 24
$704.6M
$813.5M
Q2 24
$678.9M
$910.1M
Q1 24
$653.5M
$813.5M
Total Assets
ASTH
ASTH
MNDY
MNDY
Q4 25
$2.2B
Q3 25
$2.2B
$1.7B
Q2 25
$1.4B
$2.0B
Q1 25
$1.3B
$1.7B
Q4 24
$1.4B
Q3 24
$1.3B
$1.3B
Q2 24
$1.3B
$1.5B
Q1 24
$1.2B
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
MNDY
MNDY
Operating Cash FlowLast quarter
$-2.9M
$234.4M
Free Cash FlowOCF − Capex
$-6.0M
$224.6M
FCF MarginFCF / Revenue
-0.6%
31.9%
Capex IntensityCapex / Revenue
0.3%
1.4%
Cash ConversionOCF / Net Profit
-0.44×
25.02×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$608.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
MNDY
MNDY
Q4 25
$-2.9M
Q3 25
$10.0M
$234.4M
Q2 25
$90.9M
$147.7M
Q1 25
$16.6M
$92.0M
Q4 24
$-10.9M
Q3 24
$34.0M
$156.9M
Q2 24
$23.2M
$90.3M
Q1 24
$6.0M
$42.7M
Free Cash Flow
ASTH
ASTH
MNDY
MNDY
Q4 25
$-6.0M
Q3 25
$7.4M
$224.6M
Q2 25
$89.5M
$141.8M
Q1 25
$13.6M
$90.5M
Q4 24
$-13.5M
Q3 24
$31.7M
$151.4M
Q2 24
$20.4M
$85.6M
Q1 24
$5.6M
$39.2M
FCF Margin
ASTH
ASTH
MNDY
MNDY
Q4 25
-0.6%
Q3 25
0.8%
31.9%
Q2 25
13.7%
31.3%
Q1 25
2.2%
41.7%
Q4 24
-2.0%
Q3 24
6.6%
28.7%
Q2 24
4.2%
25.3%
Q1 24
1.4%
24.1%
Capex Intensity
ASTH
ASTH
MNDY
MNDY
Q4 25
0.3%
Q3 25
0.3%
1.4%
Q2 25
0.2%
1.3%
Q1 25
0.5%
0.7%
Q4 24
0.4%
Q3 24
0.5%
1.0%
Q2 24
0.6%
1.4%
Q1 24
0.1%
2.2%
Cash Conversion
ASTH
ASTH
MNDY
MNDY
Q4 25
-0.44×
Q3 25
26.69×
25.02×
Q2 25
9.65×
6.91×
Q1 25
2.48×
12.99×
Q4 24
Q3 24
2.11×
Q2 24
1.21×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

MNDY
MNDY

Segment breakdown not available.

Related Comparisons